Abstract：Objective To investigate the effect of radiation boost (Boost) on further improving overall survival (OS) and intracranial progression-free survival (IPFS) of small-cell lung cancer (SCLC) brain metastases (BM) patients treated by whole-brain radiotherapy (WBRT). Methods A retrospective analysis of 142 consecutive SCLC BM patients admitted between 2013 and 2015 was conducted after excluding those with historical prophylactic cranial irradiation (n=16) or SRT (n=10) or local RT alone (n=1).The Kaplan-Meier curve was utilized to calculate the survival rate. The log-rank test and multivariate Cox proportional hazard regression model were utilized to evaluate clinical prognosis. Results All patients were aged 59.6 years old on average, and the female proportion was 23%. The quantity of brain metastasis lesion was 1 in 35%, 2-3 in 23% and ≥4 in 42%, respectively. The proportion of patients receiving chemotherapy was 70%. The median OS was 9.0 months and the median IPFS was 7.3 months. The accumulative mortality rate in the non-radiation (n=53), WBRT (n=33) and WBRT+ Boost (n=56) groups was 92%, 79% and 73%, and the accumulative failure rate (death or new/relapsed brain metastasis) was 94%, 82% and 80%, respectively. Compared with the non-radiation group, WBRT and WBRT+ Boost therapies exerted significant effect upon OS (P=0.000 and 0.000) and IPFS (P=0.000 and 0.000). Compared with WBRT alone, WBRT+ Boost treatment exerted no significant effect upon OS (P=0.41 and 0.51). Conclusions WBRT can significantly improve OS and IPFS of patients with SCLC-BM. However, concurrent and additional radiation boost does not further improve the survival rate.
Li Zhensheng,Shen Dongxing,Shen Xiaofei et al. Radiation boost does not help whole-brain radiotherapy further improve survivals of SCLC brain metastasis patients[J]. Chinese Journal of Radiation Oncology, 2018, 27(6): 553-558.
[1] Gavrilovic IT,Posner JB.Brain metastases:epidemiology and pathophysiology[J].J Neurooncol,2005,75(1):5-14.DOI:10.1007/s11060-004-8093-6. [2] Gaspar LE,Mehta MP,Patchell RA,et al. The role of whole brain radiation therapy in the management of newly diagnosed brain metastases:a systematic review and evidence-based clinical practice guideline[J].J Neurooncol,2010,96(1):17-32.DOI:10.1007/s11060-009-0060-9. [3] Saito EY,Viani GA,Ferrigno R,et al. Whole brain radiation therapy in management of brain metastasis:results and prognostic factors[J].Radiat Oncol,2006,1:20.DOI:10.1186/1748-717X-1-20. [4] Tsao MN,Rades D,Wirth A,et al. Radiotherapeutic and surgical management for newly diagnosed brain metastasis (es):an American society for radiation oncology evidence-based guideline[J].Pract Radiat Oncol,2012,2(3):210-225.DOI:10.1016/j.prro.2011.12.004. [5] Kim KH,Cho BC,Lee CG,et al. Hippocampus-sparing whole-brain radiotherapy and simultaneous integrated boost for multiple brain metastases from lung adenocarcinoma:early respoP=?e and dosimetric evaluation[J].Technol Cancer Res Treat,2016,15(1):122-129.DOI:10.1177/1533034614566993. [6] LiP=?key ME,Andrews DW,Asher AL,et al. The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases:a systematic review and evidence-based clinical practice guideline[J].J Neurooncol,2010,96(1):45-68.DOI:10.1007/s11060-009-0073-4. [7] Zhou L,Liu J,Xue JX,et al. Whole brain radiotherapy plus simultaneous in-field boost with image guided inteP=?ity-modulated radiotherapy for brain metastases of non-small cell lung cancer[J].Radiat Oncol,2014,9:117.DOI:10.1186/1748-717X-9-117. [8] Bauman G,Yartsev S,Fisher B,et al. Simultaneous infield boost with helical tomotherapy for patients with 1 to 3 brain metastases[J].Am J Clin Oncol,2007,30(1):38-44.DOI:10.1097/01.coc.0000245473.41035.c4. [9] Lagerwaard FJ,Van Der Hoorn EAP,Verbakel WFAR,et al. Whole-brain radiotherapy with simultaneous integrated boost to multiple brain metastases using volumetric modulated arc therapy[J].Int J Radiat Oncol Biol Phys,2009,75(1):253-259.DOI:10.1016/j.ijrobp.2009.03.029. [10] Videtic GMM,Adelstein DJ,Mekhail TM,et al. Validation of the RTOG recursive partitioning analysis (RPA) classification for small-cell lung cancer-only brain metastases[J].Int J Radiat Oncol Biol Phys,2007,67(1):240-243.DOI:10.1016/j.ijrobp.2006.08.019. [11] Khuntia D,Brown P,Li J,et al. Whole-brain radiotherapy in the management of brain metastasis[J].J Clin Oncol,2006,24(8):1295-1304.DOI:10.1200/JCO.2005.04.6185. [12] Tsao MN,Lloyd N,Wong RK,et al. Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases[J].Cochrane Database Syst Rev,2012,(4):CD003869.DOI:10.1002/14651858.CD003869.pub3. [13] Chang EL,Wefel JS,Hess KR,et al. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation:a randomised controlled trial[J].Lancet Oncol,2009,10(11):1037-1044.DOI:10.1016/S1470-2045(09)70263-3. [14] Kazda T,Jancalek R,Pospisil P,et al. Why and how to spare the hippocampus during brain radiotherapy:the developing role of hippocampal avoidance in cranial radiotherapy[J].Radiat Oncol,2014,9:139.DOI:10.1186/1748-717X-9-139. [15] Kong DS,Lee JI,Im YS,et al. Differential impact of whole-brain radiotherapy added to radiosurgery for brain metastases[J].Int J Radiat Oncol Biol Phys,2010,78(2):385-389.DOI:10.1016/j.ijrobp.2009.08.027. [16] Monaco ⅢEA,Faraji AH,Berkowitz O,et al. Leukoencephalopathy after whole-brain radiation therapy plus radiosurgery versus radiosurgery alone for metastatic lung cancer[J].Cancer,2013,119(1):226-232.DOI:10.1002/cncr.27504. [17] Sahgal A,Aoyama H,Kocher M,et al. Phase 3 trials of stereotactic radiosurgery with or without whole-brain radiation therapy for 1 to 4 brain metastases:individual patient data meta-analysis[J].Int J Radiat Oncol Biol Phys,2015,91(4):710-717.DOI:10.1016/j.ijrobp.2014.10.024. [18] Patchell RA,Tibbs PA,Walsh JW,et al. A randomized trial of surgery in the treatment of single metastases to the brain[J].N Engl J Med,1990,322(8):494-500.DOI:10.1056/NEJM199002223220802. [19] Patchell RA,Tibbs PA,Regine WF,et al. Postoperative radiotherapy in the treatment of single metastases to the brain:a randomized trial[J].JAMA.1998,280(17):1485-1489.DOI:10.1001/jama.280.17.1485. [20] Aoyama H,Shirato H,Tago M,et al. Stereotactic radiosurgery plus whole-brain radiation therapy vs. stereotactic radiosurgery alone for treatment of brain metastases:a randomized controlled trial[J].JAMA,2006,295(21):2483-2491.DOI:10.1001/jama.295.21.2483. [21] Kocher M,Soffietti R,Abacioglu U,et al. Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases:results of the EORTC 22952-26001 study[J].J Clin Oncol,2011,29(2):134-141.DOI:10.1200/JCO.2010.30.1655. [22] Pirzkall A,Debus J,Lohr F,et al. Radiosurgery alone or in combination with whole-brain radiotherapy for brain metastases[J].J Clin Oncol,1998,16(11):3563-3569.DOI:10.1200/JCO.1998.16.11.3563. [23] Bradley KA,Mehta MP.Management of brain metastases[J].Semin Oncol,2004,31(5):693-701.DOI:10.1053/j.seminoncol.2004.07.012. [24] Zhang WW,Jiang WJ,Luan LL,et al. Prophylactic cranial irradiation for patients with small-cell lung cancer:a systematic review of the literature with meta-analysis[J].BMC Cancer,2014,14:793.DOI:10.1186/1471-2407-14-793. [25] Antoni D,Clavier JB,Pop M,et al.3D radiation therapy boost improves the outcome of whole brain radiation therapy treated RPA Ⅱ patients with one or two brain metastases[J].Int J Mol Sci,2014,15(5):7554-7562.DOI:10.3390/ijms15057554. [26] National CompreheP=?ive Cancer Network. NCCN clinical practice guidelines in oncology:small cell lung cancer,Version.1,2018[EB/OL].[2018-01-06].http://www.nccn.org/professionals/physician_gls/PDF/sclc.pdf. [27] Sperduto PW,Berkey B,Gaspar LE,et al. A new prognostic index and comparison to three other indices for patients with brain metastases:an analysis of 1,960 patients in the RTOG database[J].Int J Radiat Oncol Biol Phys,2008,70(2):510-514.DOI:10.1016/j.ijrobp.2007.06.074.
2018, Vol. 27 
